Get news updates from AACRMeetingNews.org
Subscribe below to get email updates from AACRMeetingNews.org
-
New approaches to modulating T cells explored during plenary session
(Clockwise, from top left) Sergio Quezada, PhD, Michel Sadelain, MD, PhD, Ignacio Melero. MD, PhD, and Anjana Rao, PhD, discussed approaches to developing new immunotherapies.
-
Evidence mounts for connection between gut microbiome and immune checkpoint inhibitors
The forum session featured presentations from (from left) Laurence Zitvogel, MD, PhD, Gal Markel, MD, PhD, MBA, and Christian Jobin, PhD.
-
Daily Highlights for Thursday, April 15
Program Committee Chair Charles Swanton, MBPhD, FAACR, shares some of his selections from the day’s sessions to help plan your Annual Meeting experience.
-
“Building Vaccine Confidence” forum discusses best ways to fight against misinformation and hesitancy involving COVID-19 vaccines
Panelists during this special AACR Annual Meeting event shared insights about how to work together to increase uptake of vaccinations and eradicate the COVID-19 pandemic.
-
Panelists discuss African ancestry associations with clinical outcomes in cancer
(From left) Sophia H. l. George, PhD, Khadijah A. Mitchell, PhD, MS, and Melissa B. Davis, PhD, explored the emerging basic science during the session and related live panel discussion.
-
AACR-JCA Joint Session explores tumor evolution
The symposium brought together presenters (from left) Peter J. Campbell, PhD, Seishi Ogawa, MD, PhD, Christina Curtis, PhD, MSc, and Tatsuhiro Shibata, MD, PhD.
-
AACR-ASCO session surveys latest advances about the science of kidney cancer
(Clockwise, from top left) W. Marston Linehan, MD, Padmanee Sharma, MD, PhD, Ulka N. Vaishampayan, MBBS, Howard “Skip” Burris, MD, discussed novel treatment targets and therapies.
-
Genomic analysis of single cells revolutionizes cancer research
Zemin Zhang, PhD (left), and Claudia L. Kleinman, PhD, spoke during the AACR-CSCO joint symposium about new opportunities to transform the understanding of cancer biology.
-
Joint AACR-ONS program explores mechanisms of cancer- and treatment-related cognitive impairment
(Clockwise, from top left) Cobi J. Heijnen, PhD, Catherine M. Bender, PhD, RN, Shelli Kesler, PhD, and Ida M. (Ki) Moore, PhD, RN, took part in the session and live panel discussion.